TipRanks
JW Pharmaceutical Corporation (KR:001060)
:001060
South Korea Market
001060
JW Pharmaceutical Corporation
RESEARCH TOOLSreports

JW Pharmaceutical Corporation (001060) Income Statement

― Followers

JW Pharmaceutical Corporation Income Statement

Last quarter (Q2 2026), JW Pharmaceutical Corporation's total revenue was ₩222.02B, an increase of 16.18% from the same quarter last year. In Q2, JW Pharmaceutical Corporation's net income was ₩27.89B. See JW Pharmaceutical Corporation’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₩ 774.80B₩ 719.38B₩ 748.53B₩ 684.35B₩ 606.58B
Gross Profit
₩ 359.31B₩ 323.50B₩ 335.67B₩ 287.95B₩ 234.38B
Operating Expenses
₩ 271.44B₩ 241.01B₩ 235.24B₩ 225.18B₩ 203.18B
Depreciation and Amortization
₩ 18.75B₩ 19.10B₩ 22.44B₩ 17.19B₩ 16.11B
EBITDA
₩ 106.62B₩ 110.17B₩ 89.22B₩ 73.45B₩ 45.13B
Operating Income
₩ 87.88B₩ 82.49B₩ 96.63B₩ 62.96B₩ 31.20B
Other Income/Expenses
₩ 959.35M₩ -68.60M₩ -41.79B₩ -17.60B₩ -10.67B
Pretax Income
₩ 88.84B₩ 82.42B₩ 54.84B₩ 45.36B₩ 20.53B
Net Income
₩ 61.69B₩ 65.04B₩ 37.01B₩ 31.89B₩ -919.18M
Per Share Metrics
Basic EPS
₩ 2.53K₩ 2.64K₩ 1.43K₩ 1.27K₩ -41.70
Diluted EPS
₩ 2.53K₩ 2.64K₩ 1.43K₩ 1.27K₩ -41.70
Weighted Average Shares Outstanding
 24.14M 23.32M 24.61M 23.92M 23.21M
Weighted Average Shares Outstanding (Diluted)
 24.14M 23.32M 24.61M 23.92M 23.21M
Currency in KRW

JW Pharmaceutical Corporation Earnings and Revenue History